Mutual of America Capital Management LLC boosted its position in IMAX Co. (NYSE:IMAX – Free Report) by 44.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 158,022 shares of the company’s stock after acquiring an additional 48,266 shares during the quarter. Mutual of America Capital Management LLC’s holdings in IMAX were worth $2,373,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Tower Research Capital LLC TRC increased its holdings in shares of IMAX by 164.8% in the third quarter. Tower Research Capital LLC TRC now owns 3,260 shares of the company’s stock worth $46,000 after buying an additional 2,029 shares during the period. SRS Capital Advisors Inc. increased its holdings in shares of IMAX by 11.1% in the first quarter. SRS Capital Advisors Inc. now owns 6,492 shares of the company’s stock worth $125,000 after buying an additional 650 shares during the period. SG Americas Securities LLC purchased a new position in shares of IMAX in the third quarter worth about $139,000. State of Wyoming purchased a new position in shares of IMAX in the second quarter worth about $151,000. Finally, Engineers Gate Manager LP purchased a new position in shares of IMAX in the third quarter worth about $152,000. Institutional investors own 93.51% of the company’s stock.
IMAX Price Performance
NYSE IMAX opened at $17.14 on Friday. The stock has a market capitalization of $907.30 million, a PE ratio of 37.25, a PEG ratio of 1.54 and a beta of 1.25. IMAX Co. has a 1 year low of $13.20 and a 1 year high of $21.82. The business’s 50-day moving average is $16.13 and its 200 day moving average is $16.14.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Wedbush reiterated an “outperform” rating and issued a $22.00 price objective on shares of IMAX in a report on Thursday. Rosenblatt Securities decreased their price objective on IMAX from $30.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, February 13th. B. Riley cut their target price on IMAX from $27.00 to $21.00 and set a “buy” rating on the stock in a research note on Tuesday, January 2nd. The Goldman Sachs Group cut their target price on IMAX from $15.00 to $13.00 and set a “sell” rating on the stock in a research note on Thursday, January 11th. Finally, JPMorgan Chase & Co. cut their target price on IMAX from $20.00 to $17.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $20.57.
Read Our Latest Analysis on IMAX
Insider Buying and Selling at IMAX
In other IMAX news, VP Robert D. Lister sold 25,000 shares of IMAX stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $16.87, for a total transaction of $421,750.00. Following the sale, the vice president now directly owns 138,889 shares of the company’s stock, valued at approximately $2,343,057.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 24.33% of the company’s stock.
IMAX Company Profile
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Featured Articles
- Five stocks we like better than IMAX
- The How and Why of Investing in Biotech Stocks
- Comprehensive Analysis of PayPal Stock
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- What Investors Need to Know About Upcoming IPOs
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Co. (NYSE:IMAX – Free Report).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.